CONSORTIUM PARTNERS
The ACT-CHIK consortium brings together 7 partner institutions across 4 continents, combining global expertise to accelerate the development and evaluation of a safe and effective chikungunya vaccine for populations at risk.
Institut Pasteur; Paris, France
Project coordinator, developer of the MV-CHIK vaccine platform.
University of Rwanda; Kigali, Rwanda
Scientific project leadership; clinical trial site
Institut Pasteur de Dakar; Dakar, Senegal
Vaccine technology transfer recipient; clinical laboratory assays; clinical trial site
Fundação Oswaldo Cruz – Fiocruz; Rio de Janeiro, Brazil
Clinical trial material manufacturing (fill & finish); technology transfer support
Irrua Specialist Teaching Hospital; Irrua, Nigeria
Clinical trial site; Coordinating Principal Investigator
Kenya Medical Research Institute (KEMRI); Nairobi, Kenya
Clinical trial site; Lead of data dissemination and communication
International Vaccine Institute – IVI; Seoul, South Korea
Clinical trial sponsor, regulatory strategy and capacity building.
